LGDN Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Ligand Pharmaceuticals Inc

Watchlist Manager

Watchlist

Price: 196 EUR 0.51% Market Closed

Market Cap: €3.5B

L	Ligand Pharmaceuticals Inc F:LGDN	US
B	Bridgestone Corp DUS:BGT	JP
C	Ceconomy AG XHAM:CEC1	DE
D	Dubber Corp Ltd OTC:DUBRF	AU
C	Check Point Software Technologies Ltd XBER:CPW	IL
	Nanofilm Technologies International Ltd OTC:NNFTF	SG
	D'Ieteren Group NV XBRU:DIE	BE
A	Avis Budget Group Inc SWB:CUCA	US
	Ferrovial SA F:UFG	ES
A	Allgeier SE XBER:AEIN	DE
	Kernel Holding SA OTC:KARNF	UA
	Iridium Communications Inc LSE:0JDO	US

Profitability Summary

Ligand Pharmaceuticals Inc's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Exceptional Gross Margin

95%

Strong 3Y Average Gross Margin

88%

Gross Margin is Increasing

72% > 95%

Healthy Operating Margin

18%

Low 3Y Average Operating Margin

Declining Operating Margin

20% > 18%

Exceptional Net Margin

46%

Sustainable 3Y Average Net Margin

15%

Net Margin is Increasing

13% > 46%

Exceptional Free Cash Flow Margin

18%

Strong 3Y Average Free Cash Flow Margin

24%

Declining Free Cash Flow Margin

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.